Analyst Corner: Maintain ‘add’ on GSK Pharma with TP of Rs 1,613

Company has impaired Vemgal by Rs 1.19 billion to reflect the estimated realisable value of Rs 1.8 billion at which it is being sold to Hetero. Hence, reported PAT declined 89.6% y-o-y. Adjusting for it PAT fell 20.0% y-o-y t

Lower employee and S,G&A expenses cushioned the drop in Ebitda margin to 140 bps y-o-y.

Godrej Consumer Products shares zoom 25% on HUL’s Sudhir Sitapati’s appointment as MD and CEO, Q4 results

Godrej Consumer Products share price zoomed 25 per cent to a fresh 52-week high of Rs 894 apiece intraday on BSE, a day after the company posted a 59 per cent on-year rise in consolidated net profit

Godrej Consumer Products, HUL, Sudhir Sitapati, Hindustan unilever Ltd, Q4 results

GSK Pharma rating – Add: Sale of plant to improve return ratios

Trend of recovery in acute therapies likely to continue; ‘Add’ rating retained with revised TP of Rs 1,575

Analyst Corner – GlaxoSmithKline Pharma: Maintain ‘add’ with revised TP of Rs 1,575

We expect this trend in recovery in the acute therapies to continue in the coming quarters. GSKP’s exposure only to domestic formulations, strong balance sheet and strong brand equity augurs well. Maintain ADD with a revise

In a prudent decision, GSKP impaired the asset to the tune of Rs6.4bn in its Dec’20 quarterly results and was exploring all options for the plant including sale.

GSK seeks lead in triple lung drug market with 2016 filing plan

The US drug filing will include clinical trials data now in hand from the closed triple combination therapy development programme, as well as....

GlaxoSmithKline posts loss as it integrates new businesses

Drug makers like GSK have been trying to focus on strengths amid competition from generic drug makers British-based drug maker GlaxoSmithKline posted a loss of ₤428 million for the fourth quarter of 2015 compared with a pro

Glenmark in agreement with Celon Pharma

Glenmark obtains semi-exclusive marketing and distribution rights for the product across 15 European countries, including Great Britain and Germany upon commercialisation Glenmark Pharmaceuticals Europe has entered into a str

Novartis acquires all remaining rights to GSK’s Ofatumumab

To develop treatments for MS and other autoimmune indications

GlaxoSmithKline faces new corruption allegations, this time in Romania

Drugmaker GlaxoSmithKline , which was fined a record 3 billion yuan ($483 million) for corruption in China last year and is examining possible staff misconduct elsewhere, faces new allegations of bribery in Romania.

gsk corruption

MSF takes to social media to pressurise GSK, Pfizer to cut price of flu shot

Urges public to #AskPharma how developing countries can get ‘A FAIR SHOT’ when vaccine prices are being kept secret

Snapdeal beefs up its top management

Sandeep Komaravelly, who spearheaded Snapdeal’s marketing function for five years, has moved to another strategic leadership role within the company.

GSK agrees UK deal for meningitis shot after Novartis stand-off

Britain will become the first country in the world to have a nationwide vaccination programme for the potentially deadly childhood disease

Novartis completes series of transactions with GlaxoSmithKline

Acquires certain oncology products and pipeline compounds from GSK

Sun Pharma to buy GSK’s opiates biz in Oz

To buy GSK’s opiates business in Australia

Sun Pharma buys GSK Opiates Australia business

Pharma major looks to strengthen its portfolio of opiates and access strong capabilities in segment

Sun Pharma to buy GSK’s Opiates business in Australia

Drug major Sun Pharma will acquire GlaxoSmithKline's Opiates business in Australia for an undisclosed amount...

Sun Pharma, Sun Pharma shares, Sun Pharma GlaxoSmithKline, GlaxoSmithKline, glaxosmithkline india, glaxosmithkline products

Fortune announces list of 2015 ‘World’s Most Admired Companies’

Fortune magazine has announced its list of 2015 ‘World’s Most Admired Companies.’ The companies on the world’s most admired list were rated based on nine key attributes, including innovativeness, sound financi

61 firms made open offers worth Rs 23,000 cr in 2014

As many as 61 listed companies made open offers worth over Rs 23,000 crore in 2014 against 81 firms in previous year as buoyant...

united spirits share price, Sensex

Frost & Sullivan releases drug launch and Phase III trial watch list for top therapeutic areas

Oncology, autoimmune and infectious diseases/vaccines are areas for novel therapeutics and in vitro diagnostics in 2015

CCI approves multi-billion dollar deal between GlaxoSmithKline and Novartis

It involves acquisition of GSK's portfolio of oncology products by Novartis for $16 billion

IPAB removes 2 trademarks held by Ajanta Pharma skin products

The Intellectual Property Appellate Board has ordered removal of Clinoxide and Clinoxide-A marks in Class 5...

FTSE steadies after gaining on Draghi’s comments

Britain's top drugmaker GlaxoSmithKline fell 2 percent.

Income Tax Calculator, Budget 2019, How to Calculate Income Tax

US Stock Market

View All


Stock Market

Most Read


Top News


Related Articles